Drug Type Small molecule drug |
Synonyms CK-15, VIDA-5, VS-105 |
Target |
Mechanism VDR modulators(Vitamin D receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC27H44O4 |
InChIKeyUECLGFUOBJOZRT-PIOAYZOASA-N |
CAS Registry1469985-12-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Kidney Diseases | Phase 2 | CN | 14 Jun 2021 | |
Chronic Kidney Diseases | Phase 2 | CN | 14 Jun 2021 | |
Hyperparathyroidism, Secondary | Phase 2 | CN | 14 Jun 2021 | |
Hyperparathyroidism, Secondary | Phase 2 | CN | 14 Jun 2021 | |
Nephrosis | Phase 2 | CN | 14 Jun 2021 | |
Nephrosis | Phase 2 | CN | 14 Jun 2021 | |
Kidney Failure, Chronic | Phase 1 | US | 24 Jan 2017 |
Not Applicable | - | VS-105 (10 nM) | yzkhvvawgx(exzevopvqy) = dcphfirefq pcczrefqcu (ylsjzrehaf ) View more | Positive | 11 Nov 2014 | ||
VS-105 (100 nM) | lextuzxtsj(mrhdvqfmhl) = tsqbmrflet dtaqeiexpf (zarqwmbotw, 1641.6) | ||||||
Not Applicable | - | hyefduhypm(rvuxcuudhe) = dpkhsnhjhf nzbrhmwzzd (ldmkzladyj ) | Positive | 11 Nov 2014 | |||
hyefduhypm(rvuxcuudhe) = pqzkqanmef nzbrhmwzzd (ldmkzladyj ) | |||||||
Not Applicable | - | qrsulbcbyb(bxfsqsbsar) = ihearozgon ksvghlikdc (ceruqgcgbw ) | - | 05 Nov 2013 | |||
qrsulbcbyb(bxfsqsbsar) = lqnnonfbwr ksvghlikdc (ceruqgcgbw ) |